Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

Treatment guidelines for erectile dysfunction

Nov. 8, 1996

Little time devoted to treating male infertility in U.S.

Nov. 8, 1996

Scotia clarifies questions regarding its PLA dossier for Tarabetic

Nov. 8, 1996

Novo Nordisk/Takeda diabetes collaboration

Nov. 8, 1996

Phase IIb/IIc trials with CholestaGel

Nov. 8, 1996

Federal Circuit affirms patent judgment for Amgen against Genetics Institute

Nov. 8, 1996

Squalene synthase inhibitors reported by RPR

Nov. 8, 1996

Yamanouchi discloses hypocholesterolemic agents

Nov. 8, 1996

NPS and SKB extend osteoporosis research collaboration

Nov. 8, 1996

Interpore and Quantic to develop cartilage repair product

Nov. 8, 1996

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...